| MR
Spectroscopy of Brain Tumors Hall C |
| M 1388. Automated Classification of In Vivo Short-Echo Time 1H Spectra of Human Brain Tumours from Two Different Centres Using Principal Component Analysis, A.R. Tate, S.J. Barton, F. Howe, J.R. Griffiths, A. Moreno, I. Barba and C. Arús, St George's Hospital Medical School, London, UK and Centre Diagnòstic Pedralbes and Universitat Autònoma de Barcelona, Barcelona, Spain. |
| T 1389. Grade-Dependent Cellular Metabaolite Changes in Patients with Glial Tumors: Assessment with in vivo 1H MR Spectroscopy, G-W. Jeong, J-J. Seo, H-K. Kang, Y-H. Kim, Y-Y. Jeong, J-G. Park, J-B. Kim, S-J. Park and H-J. Kim, Chonnam University Hospital and Chonnam National University, Kwang-Ju, Korea. |
| W 1390. Short-Echo Time 1H Macromolecule and Metabolite Spectra of Intracranial Tumors, T. Nägele, U. Seeger, I. Mader, U. Klose, M. Bitzer, W. Grodd and K. Voigt, University of Tübingen, Germany. |
| Th 1391. Correlation of 1H MRSI, rCBV, and ADC to Image Guided Biopsies of Human Brain Tumors, M. Hanna, S. Noworolski, R. Henry, A. Bollen, M. Day, C. Dowling, M. McDermott, M. Berger, W. Dillon, S. Nelson and D. Vigneron, University of California, San Francisco, CA, USA. |
| M 1392. Quantitative Brain Tumor Pathology with HRMAS Proton MR Spectroscopy, L.L. Cheng, D.C. Anthony, D.N. Louis, A.A. Tzika, P.M. Black and R.G. Gonzalez, Massachusetts General Hospital, Boston Children's Hospital, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. |
| T 1393. Detection of an Unknown 1H MRS Signal at 2.37-2.40 ppm in Patients with Severe Late-delayed Radiation Injuries, D. Yeung, Y.L. Chan, S.F. Leung, G. Cao and C. Metreweli, Prince of Wales Hospital, Chinese University of Hong Kong and Philips Medical Systems, Hong Kong, China. |
| W 1394. Single Voxel Proton MRS Matches CSI in Efficacy of Human Brain Tumor Differentiation and Treatment Response Diagnosis, A. Lin, S. Bluml, W. Caton, C. Duma, A. Mamelak, R. Rand, S. Wiseman and B.D. Ross, Huntington Medical Research Institutes, Pasadena, CA, USA; Rudi Schulte Research Institute, Santa Barbara, CA, USA and Southern California Clinical Spectroscopy Service, Pasadena, CA, USA. |
| Th 1395. Quantitative Proton-Decoupled 31P MRS of Human Brain Tumors, A.P. Lin, S. Bluml, K.J. Seymour, J.P. Tan, R. Rand and B.D. Ross, Huntington Medical Research Institutes, Pasadena, CA, USA; Rudi Schulte Research Institute, Santa Barbara, CA, USA; Southern California Clinical Spectroscopy Service, Pasadena, CA, USA and John Wayne Cancer Center, Santa Monica, CA, USA. |
| M 1396. Phosphorus-31 NMR Spectroscopy in Patients with Advanced Neck Tumors During Radiotherapy, M. Becker, H.P. Schlemmer, P. Bachert, A. Dietz, B. Vanselow, V. Rudat, M.V. Knopp, H. Weidauer, M. Wannenmacher and G. van Kaick, University of Heidelberg, Heidelberg, Germany. |
| T 1397. Nosologic Image: A Tool for Analyzing Proton Magnetic Resonance Spectroscopic Images (1H MRSI) of Brain Tumors, C. Rubin, F. Szabo de Edelenyi, C. Segebarth, M. Decorps, C. Rémy, F. Esteve, S. Grand and J.F. Lebas, Centre Hospitalier Universitaire, Grenoble, France. |
| W 1398. Statistical Classification of Metabolites in Low Grade Gliomas with 1H MRSI, T.R. McKnight, S.M. Noworolski, W.P. Dillon, D.B. Vigneron and S.J. Nelson, University of California, San Francisco, CA, USA. |